Agenus, Inc. (AGEN)
6.165
+0.12
(+2.07%)
USD |
NASDAQ |
Oct 19, 16:00
6.165
0.00 (0.00%)
After-Hours: 16:50
Agenus Cash from Operations (Annual) : -77.20M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -77.20M |
| December 31, 2024 | -158.32M |
| December 31, 2023 | -224.20M |
| December 31, 2022 | -175.37M |
| December 31, 2021 | 10.14M |
| December 31, 2020 | -139.10M |
| December 31, 2019 | -18.68M |
| December 31, 2018 | -131.09M |
| December 31, 2017 | -94.23M |
| December 31, 2016 | -79.96M |
| December 31, 2015 | -47.18M |
| December 31, 2014 | -38.23M |
| December 31, 2013 | -19.53M |
| December 31, 2012 | 1.013M |
| December 31, 2011 | -16.25M |
| Date | Value |
|---|---|
| December 31, 2010 | -14.76M |
| December 31, 2009 | -24.19M |
| December 31, 2008 | -28.91M |
| December 31, 2007 | -26.69M |
| December 31, 2006 | -44.94M |
| December 31, 2005 | -66.33M |
| December 31, 2004 | -60.22M |
| December 31, 2003 | -51.19M |
| December 31, 2002 | -50.83M |
| December 31, 2001 | -36.83M |
| December 31, 2000 | -15.13M |
| December 31, 1999 | -13.46M |
| December 31, 1998 | -6.377M |
| December 31, 1997 | -3.518M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 651.56M |
| AVITA Medical, Inc. | -31.20M |
| Iovance Biotherapeutics, Inc. | -302.41M |
| Amgen, Inc. | 9.958B |
| Anika Therapeutics, Inc. | 11.19M |